Complaint Investigation Report

Review of R1’s medication administration record for Dorzolamide-Timiolol, Latanoprost, and Erythromycin eyedrops in September and October 2024 showed that R1 received their eyedrops. Review of R1’s medication administration record for November and December 2024 indicated that facility had estradiol cream available and administered it appropriately. LPA is unable to review R1’s eyedrops or estradiol cream as it is no longer available. Interview conducted with the licensees stated that the facility was not allowed to communicate with R1's Primary Care Physician or medical professionals at all and that all communication with medical was done through R1’s responsible party.

Review of R1’s physician orders for Fosfomycin Tromethamine stated “Take 1 packet by mouth every 72 hours.” Review of R1’s medication administration record showed that R1 received this medication on 10/24/2023, 10/26/2023, and 10/28/2023.

Based on record review and observations made, this allegation is Substantiated . A finding that the Complaint allegation is Substantiated means that the allegation is valid because the preponderance of the evidence standard has been met.

Deficiencies are cited from the California Code of Regulations (CCRs), and/or the Health and Safety Code. Failure to correct the cited deficiency(ies), on or before the Plan of Correction (POC) due date, may result in a civil penalty assessment.

Exit interview conducted. Copy of report, Plan of Corrections, and Appeal Rights, discussed and provided to Executive Director. Signature on form confirms receipt of documents.